InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Sablich Kim. Officer active across 2 companies, notably Jazz Pharmaceuticals plc. In total, 8 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €555k. Activity tracked since 5 June 2021. The latest transaction was filed on 5 June 2023 (Disposition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sablich Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
2,082 股@ US$129.7314.0% 占其流量Ordinary SharesSEC:0001765581-23-000046:0
1,752 股@ US$139.4212.9% 占其流量Ordinary SharesSEC:0001765581-23-000036:0
10,429 股0Ordinary SharesSEC:0001765581-23-000017:0
1,759 股@ US$149.250.0017% mcap18.7% 占其流量Ordinary SharesSEC:0001765581-22-000057:0
6,000 股0Common StockSEC:0001140361-22-009263:0
9,953 股0Ordinary SharesSEC:0001765581-22-000028:0
2,748 股@ US$135.007425.6% 占其流量Ordinary SharesSEC:0001765581-21-000125:0
1,452 股@ US$176.4716.7% 占其流量Ordinary SharesSEC:0001765581-21-000061:0
8 条申报中的 8 条
About Sablich Kim
Sablich Kim is a director at Jazz Pharmaceuticals plc and Eiger BioPharmaceuticals, Inc.
